Biotech RadarJobs updated

COMPANY

BPGbio

HQ: Waltham, MA source · bpgbio.com ↗

Profile checked Oct 20, 2026

Develops mitochondrial-targeted therapies; lead drug BPM31510 is in a Phase 2 study in newly diagnosed glioblastoma. From company website Source · Source · checked Oct 20, 2026

Timeline

  1. Clinical Reported encouraging preliminary data from its ongoing Phase 2 study of BPM31510 in newly diagnosed glioblastoma. Source: company press release. source ↗
Feedback